ExoLab Italia emerged in the tumultuous year of 2020, born from a vision shared by pioneers Valerio Carconi and Lorenzo Cilli, seasoned veterans of multinational corporations and successful entrepreneurs, and esteemed researchers Mariantonia Logozzi and Stefano Fais, who collectively bring seven decades of scientific dedication from their tenure at the Istituto Superiore di Sanità. At a time when the world was pivoting to meet unprecedented challenges, our founders united with a common goal: to harness the bountiful offerings of Italian organic agriculture and transform them into a conduit for high-level scientific breakthroughs in the field of plant-derived exosomes.

At the heart of ExoLab Italia’s innovation lies the extraordinary nature of plant-derived exosomes. These microscopic extracellular vesicles are the lifeblood of intercellular communication within plants, carrying a plethora of proteins, lipids, ATP and RNA molecules. Mirroring the complexity of their human counterparts (Mammalian Exosomes), plant-derived exosomes exhibit unique properties that hold immense promise for human health. They are master adapters, natural carriers that merge seamlessly into the human biological landscape, offering potential breakthroughs in delivering therapeutic agents and nutrients. Harvested from the purest Italian organic produce, our exosomes encapsulate the resilience and vitality of nature. They are a testament to our belief that the most profound healing mechanisms are cultivated from the earth and refined through the precision of science.